Sefer Gezer to Aged
This is a "connection" page, showing publications Sefer Gezer has written about Aged.
Connection Strength
0.038
-
Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study. Clin Orthop Relat Res. 2011 Jan; 469(1):131-7.
Score: 0.009
-
Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma. 2004 Oct; 45(10):2099-104.
Score: 0.006
-
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res. 2004 Aug; 28(8):791-803.
Score: 0.006
-
Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leuk Res. 2000 Aug; 24(8):671-80.
Score: 0.005
-
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood. 2000 Mar 01; 95(5):1580-7.
Score: 0.004
-
Biologic characteristics of patients with hypocellular myelodysplastic syndromes. Leuk Res. 1999 Apr; 23(4):357-64.
Score: 0.004
-
Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur J Haematol. 1999 Feb; 62(2):90-4.
Score: 0.004